Informa’s Global Generics & Biosimilars Awards Slated for Milan, Italy This Summer

Informa’s Global Generics & Biosimilars Awards Slated for Milan, Italy This Summer

London – 5 March, 2021 – Planning is underway for the 2021 Global Generics & Biosimilars Awards. The awards, now in their eighth year, celebrate successes across the generics, biosimilars, and value-added medicines industries. The event will be held on November 10, 2021 in Milan, Italy and is now accepting entries based on activities undertaken between July 1, 2020 – June 30, 2021.

“The Global Generics & Biosimilars Awards are always a highlight of the calendar and provide the perfect opportunity to highlight the off-patent sector’s greatest achievements over the past year,” said Generics Bulletin executive editor David Wallace. “At a time when people appreciate the value of the pharmaceutical industry more than ever, this is the one night of the year when generics, biosimilars and value-added medicines companies and their industry partners can put their work centre stage.”

Established in 2014, the Global Generics & Biosimilars Awards honor the outstanding achievements of companies and individuals whose contributions are making medications more affordable for patients while making commercial advancements in the generics, biosimilars and value-added medicines industries.

The 14 Awards categories celebrate excellence in an array of areas including business development initiatives, commercial strategies, product development and corporate social responsibility. Outstanding contributions by companies and notable achievements by company leadership will also honoured at the ceremony to be held on November 10, 2021. The Global Generics & Biosimilars Awards are free to enter and free to attend via complimentary tickets.

“Whether you focus on generics, biosimilars or value added medicines, whether you are a small or a large company, and wherever you operate in the world, there is a category at the Global Generics & Biosimilars Awards to recognize your achievements,” commented Generics Bulletin executive editor David Wallace. “I look forward to this year’s entries and to seeing the leading lights of the industry once again gather to celebrate their best and brightest in November.”

For the complete list of awards categories, criteria and information regarding submitting a nomination, visit.

About Informa Pharma Intelligence

Trusted by over 3,000 of the world’s leading pharmaceutical companies, CROs, med and biotech organizations, and consumer healthcare organizations, the Pharma Intelligence suite of intelligence solutions delivers vital, accurate, and timely intelligence about the drug development pipeline to pharmaceutical and biomedical decision makers around the world.

At Pharma Intelligence, global teams of subject area experts follow and analyze key diseases, clinical trials, drug approvals and R&D activities as part of the breadth and depth of data available to customers. For more information visit pharmaintelligence.informa.com.

About Generics Bulletin

For nearly 20 years, Generics Bulletin has been bringing subscribers comprehensive coverage of the global generics, biosimilars, and value-added medicines industries. Part of the Informa Pharma Intelligence suite of industry intelligence solutions, Generics Bulletin provides news and analysis to aide decision makers in understanding the implications of industry developments and trends. Coverage includes news and interviews with key opinion leaders.